In this work, we found that ASPM is highly expressed, at both mRNA and protein levels, in liver cancer tissues, especially in early recurrent HCC, and up‐regulation of ASPM is significantly related to malignant clinicopathological features and short overall survival in patients with liver cancer. Here, ASPM is linked to hepatocellular carcinoma.